Sand Hill Global Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Sand Hill Global Advisors's VRTX Position: Q2 2026 in Review
Sand Hill Global Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 7.6% in Q2 2026, selling an estimated $215K and leaving 5,885 shares worth $2.92M. The position accounts for 0.09% of the portfolio, ranked #99.
Sand Hill Global Advisors first reported a position in VRTX in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.36M in Q1 2025. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Sand Hill Global Advisors held 5,885 shares of Vertex Pharmaceuticals worth $2.92M as of Q2 2026.
- Sand Hill Global Advisors sold 484 Vertex Pharmaceuticals shares in Q2 2026, an estimated $215K.
- Vertex Pharmaceuticals made up 0.09% of Sand Hill Global Advisors's portfolio in Q2 2026, its #99 holding.
- Sand Hill Global Advisors first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
- Sand Hill Global Advisors's Vertex Pharmaceuticals position peaked at $3.36M in Q1 2025.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Sand Hill Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.